FTO and IGF2BP1 mainly engaged in the IME modulation of the AD process in 21 m6A genes, and SYNC and MAPK1IP1L were also involved in AD with a high m6A level context. The gene discussed is IGF2BP1; the disease is Alzheimer disease.